Top Abstract Purchase Related
Home
>
Node
>
Subnode

Five cases of myelodysplastic syndrome treated with cytarabine ocfosfate

Nishi, T.; Funasako, M.; Hata, N.; Andoh, K.; Itoh, Y.; Ono, H.; Itoh, K.; Sato, Y.; Sato, H.; Taniji, M.; Nakai, S.; Ueda, A.; Fujimoto, H.; Ohata, M.

Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(10): 1331-1334

1996

ISSN/ISBN: 0385-0684
PMID: 8831748
Document Number: 468171
Five cases of myelodysplastic syndrome were treated with cytarabine ocfosfate. Ocfosfate (100-200 mg) was orally administered for 14 days with 14 days' interval. Etoposide was combined in one case, and nartograstim was added in two cases. Two of the five cases achieved remission, one case having complete remission, and another case showing a good response. Their remission durations were 141 and 112 days, respectively. Further improvement of therapy is needed to achieve a higher remission rate and a longer remission duration.

Document emailed within 1 workday
Secure & encrypted payments

Arai, T.; Narimiya, S.; Hayakawa, K.; Takaya, T.; Toshima, S.; Araki, M.; Uchida, A.; Yoshimi, N.; Shibuya, C.; Yasuda, Y. 1994: Successful treatment of myelodysplastic syndrome with cytarabine ocfosfate Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(7): 1085-1088
Waage, A.; Hammerstrøm, J.; Lødemel, B.; Hoff, J.E.; Langtind, J. 1986: Myelodysplastic syndrome and myelogenous leukemia. Treatment with low-dose cytarabine Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 106(6): 496-497
Kadowaki, I.; Sasaki, O.; Sasaki, T.; Ishizawa, K.; Kimura, J.; Nomura, J.; Furuyama, K.; Harigae, H.; Shishido, T.; Okuda, M. 1995: Complete remission by cytarabine ocfosfate plus G-CSF therapy in a patient with hypoplastic RAEB-T Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(1): 145-147
Hamaoka, R.; Jozaki, K.; Amano, T.; Itoh, H.; Imai, Y.; Nishikawa, M.; Kurokawa, M.; Yonezawa, T.; Chinen, Y. 1995: Low-dose cytarabine ocfosfate therapy in an elderly acute myelogenous leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(6): 819-822
Hou, M.; Deng, C.A.; Ruan, H.F. 1987: Chromosome studies in 20 cases of myelodysplastic syndrome Hua Xi Yi Ke Da Xue Xue Bao 18(4): 368-371
Chen, Y.; Wang, B.M.; Li, C.Y. 1989: Studies on CFU-Mix in 54 cases of leukemia and myelodysplastic syndrome Zhonghua Nei Ke Za Zhi 28(1): 35-38; 62-63
Fang, B.-z.; Liu, Z.-z.; He, G.-s.; Miao, M.; Wang, X.-L.; Qiu, H.-y.; Jin, Z.-m.; Tang, X.-w.; Han, Y.; Fu, Z.-z.; Ma, X.; Sun, A.-n.; Wu, D.-p.; Ruan, C.-g. 2013: Lower risk myelodysplastic syndrome patients with transfusion dependent treated by dose-reduced decitabine Zhonghua Yi Xue Za Zhi 93(40): 3189-3192
Zomas, A.; Fisfis, M.; Stefanoudaki-Sofianatou, K. 1997: Rapid disease progression in two cases of myelodysplastic syndrome (MDS) following short therapy with G-CSF Haematologica 82(2): 253-254
Bhatia, P.; Das, R.; Ahluwalia, J.; Malhotra, P.; Varma, N.; Varma, S.; Sharma, S.C.; Garewal, G. 2009: Acute leukemia/myelodysplastic syndrome as a sequelae of carcinoma breast: a report of five cases from north India Indian Journal of Pathology and Microbiology 52(2): 167-170
Shen, Y.; Xue, Y.; Li, J.; Pan, J.; Wu, Y. 2003: Clinical, cytogenetic and dual-color FISH studies on five cases of myelodysplastic syndrome or acute myeloid leukemia patients with 1;7 translocation Chinese Medical Journal 116(2): 231-234
Mandelli, F.; Petti, M.C.; Ardia, A.; Di Pietro, N.; Di Raimondo, F.; Ganzina, F.; Falconi, E.; Geraci, E.; Ladogana, S.; Latagliata, R. 1991: A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia. A multicentric study from the Italian Co-operative Group GIMEMA European Journal of Cancer 27(6): 750-755
Shlapak, D.; Kerisit, K.; Lin, C.; Wang, A.; Stumpf, B. 2013: Resident rounds. Part III: Neutrophilic eccrine hidradenitis in the setting of acute myelogenous leukemia treated with cytarabine Journal of drugs in dermatology: JDD 12(2): 231-232
Kamesaki, T.; Akifuji, Y.; Mori, M.; Ueki, J.; Nakamoto, S.; Kajii, E.; Ikemoto, S. 1993: A patient with Tn syndrome associated with myelodysplastic syndrome showed abnormal glycophorin B International Journal of Hematology 58(1-2): 113-118
Safa, G.; Joly, P.; Boullie, M.C.; Thomine, E.; Lauret, P. 1995: Melkersson-Rosenthal syndrome treated by thalidomide. 2 cases Annales de Dermatologie et de Venereologie 122(9): 609-611
Coll-Vinent, B.; Pedrol, E.; Casademont, J.; Cid, M.C.; Grau, J.M. 1994: Sweet's syndrome associated with mesenteric lipodystrophy and a myelodysplastic syndrome Presse Medicale 23(25): 1180
Masaoka, T.; Ogawa, M.; Yamada, K.; Kimura, K.; Ohhashi, Y. 1993: A late phase Ii comparative study of idarubicin + cytarabine and daunorubicin + cytarabine in adult patients with acute non-lymphocytic leukemia. Idarubicin Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(13): 1995-2005
Tao, W.-Q.; Shu, X.; Fang, H.-Y. 2012: Twenty-two cases of short bowel syndrome treated with acupuncture Zhongguo Zhen Jiu 32(3): 209-210
Yang, H.F.; Chen, F.W.; Lee, Y.S.; Hsieh, Y.F. 1971: Cushing's syndrome: clinical analysis of 24 cases treated with adrenalectomy Journal of the Formosan Medical Association 70(5): 235-241
Zamora-Pérez, E.; López-Karpovitch, X. 2015: Hematologic response predictor factors in adults with myelodysplastic syndromes (SMD) treated with cyclosporin a (CSA) Gaceta Medica de Mexico 151(3): 345-353
Sawamura, R.; Fernandes, M.I.; Galvão, L.C.; Goldani, H.A. 1996: Report of two cases of children with Budd-Chiari syndrome successfully treated with streptokinase Arquivos de Gastroenterologia 33(3): 179-181